Jiru Zhang

Jiru Zhang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Journal of Advanced Research
Verified
Journal Article
Open access
QLQing-Bo Lu
Qing-Bo Lu
YDYi Ding
Yi Ding
YLYao Liu
Yao Liu
ZWZi-Chao Wang
Zi-Chao Wang
YWYu-Jie Wu
Yu-Jie Wu
Haijian SunHaijian Sun
Haijian Sun
Meteorin-like hormone (Metrnl) is ubiquitously expressed in skeletal muscle, heart, and adipose with beneficial roles in obesity, insulin resistance, and inflammation. Metrnl is found to protect against cardiac hypertrophy and doxorubicin-induced cardiotoxicity. However, its role in diabetic cardiomyopathy (DCM) is undefined. We aimed to elucidate the potential roles of Metrnl in DCM. Gain- andloss-of-function experimentswere utilized to determine the roles of Metrnl in the pathological processes of DCM. We found that plasma Metrnl levels, myocardial Metrnl protein and mRNA expressions were significantly downregulated in both streptozotocin (STZ)-induced (T1D) mice and leptin receptor deficiency (db/db) (T2D) mice. Cardiac-specific overexpression (OE) of Metrnl markedly ameliorated cardiac injury and dysfunction in both T1D and T2D mice. In sharp contrast, specific deletion of Metrnl in the heart had the opposite phenotypes. In parallel, Metrnl OE ameliorated, whereas Metrnl downregulation exacerbated high glucose (HG)-elicited hypertrophy, apoptosis and oxidative damage in primary neonatal rat cardiomyocytes. Antibody-induced blockade of Metrnl eliminated the effects of benefits of Metrnl in vitro and in vivo. Mechanistically, Metrnl activated the autophagy pathway and inhibited the cGAS/STING signaling in a LKB1/AMPK/ULK1-dependent mechanism in cardiomyocytes. Besides, Metrnl-induced ULK1 phosphorylation facilitated the dephosphorylation and mitochondrial translocation of STING where it interacted with tumor necrosis factor receptor-associated factor 2 (TRAF2), a scaffold protein and E3 ubiquitin ligase that was responsible for ubiquitination and degradation of STING, rendering cardiomyocytes sensitive to autophagy activation. Thus, Metrnl may be an attractive therapeutic target or regimen for treating DCM.

25 February 2022 in Human Cell
Verified
Journal Article
Closed access
PDF file
PYPENG Yu
PENG Yu
JZJing Zhang
Jing Zhang
YDYi Ding
Yi Ding
DCDandan Chen
Dandan Chen
HSHaijian Sun
Haijian Sun
JZJiru Zhang
Jiru Zhang

29 May 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XZXue-Xue Zhu
Xue-Xue Zhu
GZGuan-Li Zheng
Guan-Li Zheng
QLQing-Bo Lu
Qing-Bo Lu
JSJia-Bao Su
Jia-Bao Su
YLYao Liu
Yao Liu
JZJiru Zhang
Jiru Zhang

14 October 2021 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
DCDandan Chen
Dandan Chen
YDYi Ding
Yi Ding
WZWenlan Zhu
Wenlan Zhu
TFTingting Fang
Tingting Fang
NDNan Dong
Nan Dong
JZJiru Zhang
Jiru Zhang

25 April 2024 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
Haijian SunHaijian Sun
Haijian Sun
ZNZhang-Rong Ni
Zhang-Rong Ni
YLYao Liu
Yao Liu
XFXiao Fu
Xiao Fu
SLShi-Yi Liu
Shi-Yi Liu
QLQing-Bo Lu
Qing-Bo Lu
Background: Neutral cholesterol ester hydrolase 1 (NCEH1) plays a critical role in the regulation of cholesterol ester metabolism. Deficiency of NCHE1 accelerated atherosclerotic lesion formation in mice. Nonetheless, the role of NCEH1 in endothelial dysfunction associated with diabetes has not been explored. The present study sought to investigate whether NCEH1 improved endothelial function in diabetes, and the underlying mechanisms were explored. Methods: The expression and activity of NCEH1 were determined in obese mice with high-fat diet (HFD) feeding, high glucose (HG)-induced mouse aortae or primary endothelial cells (ECs). Endothelium-dependent relaxation (EDR) in aortae response to acetylcholine (Ach) was measured. Results: Results showed that the expression and activity of NCEH1 were lower in HFD-induced mouse aortae, HG-exposed mouse aortae ex vivo, and HG-incubated primary ECs. HG exposure reduced EDR in mouse aortae, which was exaggerated by endothelial-specific deficiency of NCEH1, whereas NCEH1 overexpression restored the impaired EDR. Similar results were observed in HFD mice. Mechanically, NCEH1 ameliorated the disrupted EDR by dissociating endothelial nitric oxide synthase (eNOS) from caveolin-1 (Cav-1), leading to eNOS activation and nitric oxide (NO) release. Moreover, interaction of NCEH1 with the E3 ubiquitin-protein ligase ZNRF1 led to the degradation of Cav-1 through the ubiquitination pathway. Silencing Cav-1 and upregulating ZNRF1 were sufficient to improve EDR of diabetic aortas, while overexpression of Cav-1 and downregulation of ZNRF1 abolished the effects of NCEH1 on endothelial function in diabetes. Thus, NCEH1 preserves endothelial function through increasing NO bioavailability secondary to the disruption of the Cav-1/eNOS complex in the endothelium of diabetic mice, depending on ZNRF1-induced ubiquitination of Cav-1. Conclusions: NCEH1 may be a promising candidate for the prevention and treatment of vascular complications of diabetes.

1 September 2018 in Journal of Biotechnology
Verified
Journal Article
Closed access
JLJian-Fang Li
Jian-Fang Li
XLXue-Qing Li
Xue-Qing Li
YLYan Liu
Yan Liu
FYFeng-Jiao Yuan
Feng-Jiao Yuan
TZTing Zhang
Ting Zhang
JZJiru Zhang
Jiru Zhang